These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4659004)

  • 1. [Effect of L-ornithin-L-aspartate on toxic kidney disorders similar to nephrosis].
    Raab W
    Dtsch Med J; 1972 Dec; 23(12):705-8. PubMed ID: 4659004
    [No Abstract]   [Full Text] [Related]  

  • 2. Kaliopenic nephrosis: protective action of L-ornithine-L-aspartate.
    Raab WP
    Clin Chim Acta; 1972 Jun; 39(1):239-42. PubMed ID: 5038753
    [No Abstract]   [Full Text] [Related]  

  • 3. [The therapy of states of exhaustion with Ornithin-Aspartat].
    Simon KH
    Med Monatsschr; 1968 Jan; 22(1):30-1. PubMed ID: 5707445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate.
    Raab WP
    Arzneimittelforschung; 1971 Oct; 21(10):1620-1. PubMed ID: 5171899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
    Seki S
    Iryo; 1966 Apr; 20(4):354-63. PubMed ID: 5974194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Personal experiences in the treatment of internal diseases with ornithine aspartate].
    Perinović M; Robović Z; Grujić M; Ljubojević S
    Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protection of the liver and liver therapy with Hepamerz].
    Heynen U
    Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our clinical experience with ornithine aspartate].
    Szirmai E
    Minerva Med; 1971 Jun; 62(47):2376-82. PubMed ID: 5087700
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effect of indomethacin in experimental chronic nephrosis.
    Kleinknecht C; Laouari D; Gubler MC; Gros F
    Int J Pediatr Nephrol; 1983 Jun; 4(2):83-8. PubMed ID: 6618773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of thyroxine on the course of acute kidney failure. 3. Effect of L-thyroxine administration on glomerular filtration rate, effective renal plasma flow and tubular secretory and reabsorption capacity in rabbits with toxic renal damage (Studies using the model of the so-called sublimate nephrosis)].
    Straub E
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 155(1):56-73. PubMed ID: 5558590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of thyroxine on the course of acute renal failure. I. Effect of L-thyroxine treatment upon the mortality of rabbits and mice with manifest acute renal failure (model of so-called mercury-nephrosis)].
    Straub E
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 154(2):177-86. PubMed ID: 5549672
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with heparmez].
    Baumann M
    Z Allgemeinmed; 1970 Jun; 46(17):895-900. PubMed ID: 5509064
    [No Abstract]   [Full Text] [Related]  

  • 18. Poly-L-lysine-gold probe for the detection of anionic sites in normal glomeruli and in idiopathic and experimentally-induced nephrosis. A comparative ultrastructural study.
    Russo P; Gingras D; Bendayan M
    Am J Pathol; 1993 Jan; 142(1):261-71. PubMed ID: 8424459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protection from experimental indium sulfate nephrosis (effect of ferrous dextran)].
    Bouissou H; Voisin MC; Durroux R; Magna H
    J Urol Nephrol (Paris); 1968 Sep; 74(9):710-7. PubMed ID: 5718188
    [No Abstract]   [Full Text] [Related]  

  • 20. [Confirmation of a liver-protecting action of L-ornithine-L-aspartate using the experimental model of hypokalaemic liver damage].
    Raab W
    Wien Klin Wochenschr; 1972 May; 84(21):348-9. PubMed ID: 5031515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.